Pressroom: Media Coverage

Showing 321 - 340 of 554 news items

2012

Red Hook Movie Producer Wants to Raise Awareness of Stomach Cancer

Medical oncologist Yelena Janjigian was interviewed about her patient, Red Hook movie producer Angelica Strong, who is organizing fundraisers to raise awareness and funds for stomach cancer.

May 27, 2012
Considering the Personal and Practical Decisions with Breast Reconstruction

Plastic surgeon Andrea Pusic discussed some women’s initial aversion to breast reconstruction at the beginning of treatment. Only about a third of women undergo immediate breast reconstruction after mastectomy, according to a 2011 analysis in the Annals of Surgical Oncology, with 11.5 percent delaying reconstructive surgery for months or years, and more than half of patients foregoing it altogether.

May 24, 2012
Smoking Gene May Reveal Why Some People Smoke More

A study led by molecular epidemiologist Helena Furberg reported the discovery of a gene that predicts smoking behavior. Dr. Furberg noted that the next research step would be to see if currently available smoking cessation medications would work differently in people who carry these genes.

May 22, 2012
Moderate Weight Loss Can Decrease Breast Cancer Risk

Breast Cancer Medicine Chief Clifford Hudis commented on the connection between obesity and breast cancer risk in postmenopausal women. Cancer researchers believe fat tissue becomes a major source of estrogen, which causes certain types of tumors in the breast to grow.

May 22, 2012
Lung Cancer Tests Advised for Some Heavy Smokers

In collaboration with the American College of Chest Physicians and the American Society of Clinical Oncology, epidemiologist and physician Peter Bach led an effort to develop clinical guidelines for lung cancer screening in smokers. Published in the Journal of the American Medical Association, the guidelines were widely covered by mainstream media, including the Associated Press, Bloomberg, and HealthDay News.

May 20, 2012
Cancer Survivors Face a New Challenge in Care

Survivorship Initiative Director Mary McCabe commented on the importance of cancer survivorship programs. She said these programs ensure that cancer survivors receive proper follow-up care and teach survivors how to communicate their needs to their healthcare team.

May 17, 2012
Aveo Kidney Cancer Drug More Tolerated Than Nexavar

Medical oncologist Robert Motzer discussed encouraging findings from a phase III study he led comparing the safety and efficacy of two kidney cancer drugs. Dr. Motzer’s team found that patients taking the investigational drug tivozanib were half as likely to need a break from the medication due to side effects as patients taking sorafenib (Nexavar®).

May 16, 2012
Complex Immune-Based Cancer Treatment Shows Signs of Progress

Michel Sadelain, Center for Cell Engineering Director, discussed the burgeoning field of adoptive cell transfer (ACT) as a treatment for cancer. Dr. Sadelain, who is involved in several ACT trials at Memorial Sloan Kettering, notes that interest in these types of cell-based therapies is growing, but serious hurdles must be overcome if any form of ACT is to become widely available.

May 15, 2012
With Biotechs Back in Limelight, OPKO's Alzheimer's Diagnostic and Other Products Catch Investors' Eye

Surgery Department Chair Peter Scardino spoke about biomarkers developed at Memorial Sloan Kettering that, when used together with PSA tests, can reduce the need for prostate biopsies by more than 50 percent.

May 13, 2012
Finding a Match, and a Mission: Helping Blacks Survive Cancer

Memorial Sloan Kettering patient Seun Adebiyi launched Nigeria’s national bone marrow registry after experiencing firsthand the difficulty of finding donors for patients of African descent.

May 12, 2012
Sunscreen Fears

Dermatologist Kishwer Nehal was interviewed about research from Missouri University of Science and Technology that looked at what happens to cells containing zinc oxide when exposed to sunlight.

May 11, 2012
Risky Surgical Business

Gynecologic oncologist Douglas Levine spoke about risk-reducing surgery for carriers of BRCA gene mutations. BRCA gene mutations, which are much more prevalent in Jewish people of Ashkenazi descent than in the general population, increase the likelihood of developing ovarian or breast cancer.

May 8, 2012
Training Immune System to Fight Cancer Comes of Age

Medical oncologist Jedd Wolchok was interviewed about immunotherapy – the harnessing of the body’s immune system to fight cancer – and how it has turned certain cancers into chronic diseases for patients rather than fatal ones.

May 7, 2012
Gene Therapy Safe in Decade-Long HIV Study That May Widen Use

Michel Sadelain, Center for Cell Engineering Director, discussed encouraging findings of a recent study that found that HIV patients given gene therapy more than a decade ago are healthy and the altered DNA they received remains stable in their bodies. The study suggests that this treatment may safely be tested as a way to attack other illnesses.

May 2, 2012
Studies Reignite Mammography Debate For Middle-Aged Women

Diagnostic radiologist Carol Lee spoke about mammography for women in their 40s. Recent studies suggest that women with a low risk of breast cancer do not need regular mammograms until age 50, but Dr. Lee warns that the studies “may discourage women who don’t have an identifiable risk factor from seeking screening, and therefore the potential lifesaving benefit of screening won’t be realized.”

NPR
April 30, 2012
Do We "Waste" Money on Terminal Patients? (Part II)

Director of Memorial Sloan Kettering’s Center for Health Policy and Outcomes Peter Bach continued his discussion with American historian and broadcaster Richard Heffner about the cost of medical care.

April 28, 2012
What You Don't Know About Cancer

Human Oncology and Pathogenesis Program Chair Charles Sawyers spoke about the excitement around the emerging role of DNA in the fight against cancer. He said, “There has never been a time of greater optimism about the future of cancer therapy.”

April 23, 2012
Strides are Being Made in the Treatment of Neuroblastoma

Pediatric oncologist Shakeel Modak spoke about new treatments for neuroblastoma that are being pioneered by oncologists at Memorial Sloan Kettering.

April 23, 2012
Skin Cancer Prevention Tips

Dermatology Service Chief Allan Halpern offered skin cancer prevention tips and discussed sun safety with Martha Stewart and Debra Black of the Melanoma Research Alliance.

April 23, 2012
Do We "Waste" Money on Terminal Patients?

Director of Memorial Sloan Kettering’s Center for Health Policy and Outcomes Peter Bach discussed a recent essay he wrote in The New York Times about the amount of money spent on providing care to patients who may die.

April 21, 2012